What type of drug is Imfinzi?
- Asked
- 5 Jul 2017
- Updated
- 5 Jul 2017
- Topics
- faq, drug, imfinzi
Answers (1)
Official Answer by Drugs.com
5 Jul 2017
Imfinzi (durvalumab) is a cancer medicine that works with your immune system to slow cancer cell growth. Imfinzi is classified as an anti-PD-L1 (programmed death ligand-1) human monoclonal antibody. In May 2017, Imfinzi was given FDA-approval for the treatment of patients with advanced urothelial carcinoma (bladder cancer) who have disease progression despite use of platinum-containing chemotherapy with or without surgery.
Further Information
- Imfinzi Information for Consumers
- Imfinzi Information for Healthcare Professionals (includes dosage details)
- Side Effects of Imfinzi (detailed)
Search for questions
Still looking for answers? Try searching for what you seek or ask your own question.
Frequently Asked Questions
How does Lutathera work to treat gastroenteropancreatic neuroendocrine tumors?
Posted 7 Mar 2018 • 1 answerFAQ by Drugs.com
What is the difference between Firvanq and the CutisPharma FIRST-Vancomycin Compounding Kit?
Posted 7 Mar 2018 • 1 answerFAQ by Drugs.com
What is the difference between Biktarvy and Descovy?
Posted 7 Mar 2018 • 1 answerFAQ by Drugs.com
How does Dexycu work to treat inflammation associated with cataract surgery?
Posted 7 Mar 2018 • 1 answerFAQ by Drugs.com
What is the difference between Symdeko and Orkambi?
Posted 7 Mar 2018 • 1 answerFAQ by Drugs.com
